17/07/2025
✨ 2025 BIO Asia–Taiwan!✨
「AIRHYPER一站式吸入藥物開發平台」結合先進氣霧化技術、流道設計與流場控制、提升使用者操作介面,將藥物精準輸送至肺部深處,並即時反饋霧化遞送藥量,有效提升吸入式藥物開發的效率與可及性。
利優生醫誠摯邀請您一同參與 2025亞洲生技大展 年度盛會,期待與您在展會中交流!
🚀 At AeproMED, we’re redefining inhaled drug development with our 1-stop AIRHYPER™ Platform, powered by our proprietary AFDT and DSMT technologies.
✅ In-vitro lung deposition studies
✅ AniFree™ preclinical animal trial system
✅ NEBreath™ efficient nebulizer
With us, inhaled drug development becomes clearer, more controllable, and more effective. Together, we can co-design aerosol characteristics to maximize lung deposition and optimize therapeutic outcomes.
🤝 As your professional inhalation development partner, AeproMED makes inhalation dosage more accessible, measurable, and predictable.
📍 Exhibition Information
Date: July 24 ~ July 27
Location: Taipei Nangang Exhibition Center, Hall 1, 4F
Booth No.: N915
🔍Showcase Time
7/24 (Thu) 15:45-15:50
7/25 ( Fri ) 11:15-11:35
Visit our booth at 2025 BIO Asia–Taiwan — let’s innovate inhalation therapy together!